Literature DB >> 17953252

Laparoscopic gastric bypass with subtotal gastrectomy for a super-obese patient with Biermer anemia.

Maxime Sodji1, Frédéric A Sebag, Jean Marc Catheline.   

Abstract

Laparoscopic Roux-en-Y gastric bypass (RYGBP) is a common procedure for morbid obesity. After RYGBP, the bypassed stomach is unavailable for follow-up. Biermer anemia is an autoimmune atrophic gastritis inducing vitamin B12 deficiency and it is a risk factor for gastric carcinoma. A 41-year-old woman with a long history of morbid obesity presented with a BMI of 56 kg/m2. She had anemia (Hb 9.9 g/dL), and atrophic gastritis was found endoscopically. We performed a laparoscopic RYGBP with subtotal gastrectomy, to avoid the risk of gastric carcinoma in the bypassed stomach. The patient was discharged 9 days after the operation without complication. At 18 months follow-up, her BMI was 39 kg/m2 (50% excess weight loss). Laparoscopic RYGBP with subtotal gastrectomy is a safe treatment for morbid obesity, which should be considered for patients with a risk factor for gastric carcinoma.

Entities:  

Mesh:

Year:  2007        PMID: 17953252     DOI: 10.1007/s11695-007-9191-2

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  22 in total

1.  Investigation of the excluded stomach after Roux-en-Y gastric bypass.

Authors:  M Sundbom; R Nyman; H Hedenström; S Gustavsson
Journal:  Obes Surg       Date:  2001-02       Impact factor: 4.129

2.  Gastric cancer after Roux-en-Y gastric bypass.

Authors:  Alex Escalona; Sergio Guzmán; Luis Ibáñez; Luis Meneses; Alvaro Huete; Antonieta Solar
Journal:  Obes Surg       Date:  2005-03       Impact factor: 4.129

3.  Ghrelin levels and sleeve gastrectomy in super-super-obesity.

Authors:  Régis Cohen; Bernard Uzzan; Hélène Bihan; Inès Khochtali; Gérard Reach; Jean Marc Catheline
Journal:  Obes Surg       Date:  2005 Nov-Dec       Impact factor: 4.129

4.  Cancer in the excluded stomach 4 years after gastric bypass.

Authors:  Deborah A Corsini; Celso A M Simoneti; Gisele Moreira; Sizenando E Lima; Arthur B Garrido
Journal:  Obes Surg       Date:  2006-07       Impact factor: 4.129

5.  Mechanism of gastric bypass-induced body weight loss: one-year follow-up after micro-gastric bypass in rats.

Authors:  Björn Stenström; Marianne W Furnes; Karin Tømmerås; Unni Syversen; Chun-Mei Zhao; Duan Chen
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

6.  Retrograde endoscopy of the bypassed stomach segment after gastric bypass surgery: unexpected lesions.

Authors:  D R Sinar; E G Flickinger; H K Park; R R Sloss
Journal:  South Med J       Date:  1985-03       Impact factor: 0.954

7.  Report of two cases of gastric cancer after bariatric surgery: lymphoma of the bypassed stomach after Roux-en-Y gastric bypass and gastrointestinal stromal tumor (GIST) after vertical banded gastroplasty.

Authors:  Arnaud de Roover; Olivier Detry; Laurence de Leval; Carla Coimbra; Claude Desaive; Pierre Honoré; Michel Meurisse
Journal:  Obes Surg       Date:  2006-07       Impact factor: 4.129

8.  Virtual gastroduodenoscopy: a new look at the bypassed stomach and duodenum after laparoscopic Roux-en-Y gastric bypass for morbid obesity.

Authors:  Gianfranco Silecchia; Carlo Catalano; Paolo Gentileschi; Ugo Elmore; Angelo Restuccia; Michel Gagner; Nicola Basso
Journal:  Obes Surg       Date:  2002-02       Impact factor: 4.129

9.  Laparoscopic Roux-en-Y gastric bypass with remnant gastrectomy for focal intestinal metaplasia of the gastric antrum.

Authors:  David C Voellinger; William B Inabnet
Journal:  Obes Surg       Date:  2002-10       Impact factor: 4.129

10.  Gastroscopic follow up of pernicious anaemia patients.

Authors:  S M Sjöblom; P Sipponen; H Järvinen
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

View more
  1 in total

1.  Unexpected changes in the gastric remnant in asymptomatic patients after Roux-en-Y gastric bypass on vertical banded gastroplasty.

Authors:  Luca Leuratti; Massimo Pierluigi Di Simone; Stefano Cariani
Journal:  Obes Surg       Date:  2013-01       Impact factor: 4.129

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.